4′-substituted nucleoside reverse transcriptase inhibitors
US9777035B2 · kind B2 · utility
9Cited by
7References
59Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2015 |
| Grant date | Oct 3, 2017 |
| Priority date | — |
| Expiry date | Apr 5, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to 4′-substituted nucleoside derivatives of Formula Iand their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.